GlassScriptPhysician profile
Gail Clift
NPI 1770548000
$2,483.46
in general payments reported to CMS, 2019-2025
20 companies · $325 in 2025
The $325 reported for 2025 was more than what 86% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,026 · 2022: $746 · 2023: $221 · 2024: $165 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $590.37 | 2021-2025 | Qelbree, Qelbree |
| Otsuka America Pharmaceutical, INC. | $363.50 | 2021-2023 | Rexulti, Abilify Maintena |
| Corium, LLC | $288.80 | 2022-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $187.41 | 2021-2023 | |
| Vanda Pharmaceuticals INC. | $144.71 | 2021-2025 | Hetlioz, Fanapt |
| Ironshore Pharmaceuticals INC. | $138.79 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $130.25 | 2021-2022 | |
| Tris Pharma INC | $121.39 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $103.67 | 2021-2023 | Trintellix |
| Adlon Therapeutics L.P. | $93.24 | 2021 | |
| Sunovion Pharmaceuticals INC. | $83.72 | 2021 | |
| Abbvie INC. | $70.01 | 2025 | |
| Genentech USA, INC. | $42.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.28 | 2023 | Spravato |
| Alfasigma USA, INC. | $21.77 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $17.03 | 2021 | |
| Alkermes, INC. | $16.79 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.81 | 2025 | Jornay Pm |
| Lundbeck LLC | $15.49 | 2022 | |
| Vivus LLC | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gail Clift listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.